Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Prepaid Assets: 2020-2024

Historic Prepaid Assets for Caribou Biosciences (CRBU) over the last 5 years, with Dec 2024 value amounting to $6.6 million.

  • Caribou Biosciences' Prepaid Assets fell 19.23% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 19.23%. This contributed to the annual value of $6.6 million for FY2024, which is 7.05% up from last year.
  • According to the latest figures from FY2024, Caribou Biosciences' Prepaid Assets is $6.6 million, which was up 7.05% from $6.2 million recorded in FY2023.
  • In the past 5 years, Caribou Biosciences' Prepaid Assets ranged from a high of $7.9 million in FY2022 and a low of $3.2 million during FY2020.
  • In the last 3 years, Caribou Biosciences' Prepaid Assets had a median value of $6.6 million in 2024 and averaged $6.9 million.
  • As far as peak fluctuations go, Caribou Biosciences' Prepaid Assets skyrocketed by 126.62% in 2021, and later decreased by 22.30% in 2023.
  • Yearly analysis of 5 years shows Caribou Biosciences' Prepaid Assets stood at $3.2 million in 2020, then spiked by 126.62% to $7.2 million in 2021, then rose by 9.47% to $7.9 million in 2022, then decreased by 22.30% to $6.2 million in 2023, then climbed by 7.05% to $6.6 million in 2024.